menu
    • menu

    Company profile for Roivant Sciences

    NEW Drugs in Dev: 6
    Farmak works in the development, production and marketing of APIs, Intermediates & Specialties// FDA inspected.

    Virtual Booth

    Contact Supplier

    Minakem delivers API, HPAPI, steroids & CDMO services for generics with FDA/GMP certification, regulatory know-how & proven success.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-01-12

    Virtual Booth

    Contact Supplier

    IKF/Pharmasynthese have been with fine chemicals market and APIs performance for more than 40 years.

    Virtual Booth

    Contact Supplier

    Cosma S.p.A., part of CFM Group with AMSA & Clarochem, provides global pharma & veterinary health with 300+ tons of FDA-approved APIs.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    REF. STANDARDS & IMPURITIES

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Roivant aims to improve health by rapidly delivering innovative medicines and technologies to patients. We do this by building Vants – nimble, entrepreneurial biotech and healthcare technology companies with a unique approach to sourcing talent, aligning incentives, and deploying technology. The therapies in development across our family of companies target a wide range of diseases including uterine fibroids, endometriosis, ...
    Roivant aims to improve health by rapidly delivering innovative medicines and technologies to patients. We do this by building Vants – nimble, entrepreneurial biotech and healthcare technology companies with a unique approach to sourcing talent, aligning incentives, and deploying technology. The therapies in development across our family of companies target a wide range of diseases including uterine fibroids, endometriosis, prostate cancer, Parkinson’s disease, diabetes, pulmonary arterial hypertension, and multiple rare and fatal pediatric conditions.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Roivant SciencesUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    320 West 37th Street 6th Floor New York, NY 10018
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://roivant.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/roivant-sciences-inc-
    youtube
    YouTube
    Twitter
    Twitter
    https://x.com/roivant?lang=en

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    SCOPE Summit

    SCOPE Summit

    Not Confirmed

    envelop Contact Supplier

    SCOPE Summit

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Roivant to Report Financial Q3 2025 Results on Feb. 6
    Roivant to Report Financial Q3 2025 Results on Feb. 6

    23 Jan 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/01/23/3225069/34323/en/Roivant-to-Report-Financial-Results-for-the-Third-Quarter-Ended-December-31-2025-and-Provide-Business-Update-on-Friday-February-6-2026.html

    GLOBENEWSWIRE
    23 Jan 2026
    Share Share
    Roivant Highlights Progress and Outlook at Its 2025 Investor Day
    Roivant Highlights Progress and Outlook at Its 2025 Investor Day

    11 Dec 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/12/11/3203811/34323/en/Roivant-Highlights-Continued-Pipeline-Progress-and-Outlook-for-Company-s-Next-Phase-of-Growth-at-2025-Investor-Day.html

    GLOBENEWSWIRE
    11 Dec 2025
    Share Share
    Roivant Reports Financial Results for the Q2 Ended September 30
    Roivant Reports Financial Results for the Q2 Ended September 30

    10 Nov 2025

    // PRESS RELEASE

    https://investor.roivant.com/news-releases/news-release-details/roivant-reports-financial-results-second-quarter-ended-1

    PRESS RELEASE
    10 Nov 2025
    Share Share
    Roivant To Release Q2 2025 Financials And Business Update On Nov
    Roivant To Release Q2 2025 Financials And Business Update On Nov

    27 Oct 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/10/27/3174963/34323/en/Roivant-to-Report-Financial-Results-for-the-Second-Quarter-Ended-September-30-2025-and-Provide-Business-Update-on-Monday-November-10-2025.html

    GLOBENEWSWIRE
    27 Oct 2025
    Share Share
    Roivant and Priovant's drug show Promising Result in Rare Disease
    Roivant and Priovant's drug show Promising Result in Rare Disease

    17 Sep 2025

    // PRESS RELEASE

    https://investor.roivant.com/news-releases/news-release-details/roivant-and-priovant-announce-positive-phase-3-valor-study

    PRESS RELEASE
    17 Sep 2025
    Share Share
    Roivant Recognized in 2025 BioPharma Workplaces by Fortune Media
    Roivant Recognized in 2025 BioPharma Workplaces by Fortune Media

    11 Sep 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/09/11/3148909/34323/en/Roivant-Named-on-Fortune-Media-and-Great-Place-To-Work-s-2025-Best-Workplaces-in-BioPharma-List.html

    GLOBENEWSWIRE
    11 Sep 2025
    Share Share

    REF. STANDARDS & IMPURITIES

    Upload your portfolio for free, ask us

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search